| Identification | Back Directory | [Name]
Takeda103A | [CAS]
865609-72-9 | [Synonyms]
Takeda103A
Benzamide, N-[(2,6-difluorophenyl)methyl]-3-[[[4-propyl-5-(4-pyrimidinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]- | [Molecular Formula]
C24H23F2N7O | [MDL Number]
MFCD34564618 | [MOL File]
865609-72-9.mol | [Molecular Weight]
463.48 |
| Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: Soluble: =10 mg/ml
Ethanol: Soluble: =10 mg/ml | [form ]
Solid | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Takeda 103A novel potent inhibitor of the GRK2-- dependent bovine tubulin oxidation. | [storage]
Store at -20°C | [References]
[1] DAVID M THAL. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors.[J]. ACS Applied Electronic Materials, 2011: 294-303. DOI: 10.1124/mol.111.071522 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|